Videos
Articles
Late-Onset Anaphylaxis and Tick Exposure: Epidemiological Insights From Shizuoka
H. Hashizume, A. Matsuura, and Y. Miyachi. Allergy. First published: 09 September 2025
Multi-Omic Analysis of Scylla serrata Reveals the Allergen Landscape of Mud Crabs and Decapoda Species
K. F.-K. Ao, J. K. W. Ng, C. T.-Y. Law, et al. Allergy. First published: 09 September 2025
Premastication—Review of an Infant Feeding Practice and Its Potential Impact on Allergy and Microbiome Development
A. Steinberg, S. Goebel, T. Eckert, et al. Allergy. First published: 08 September 2025
Diversity and Dosage Determine the Efficacy of the Probiotic SYN-53 in Allergic Rhinoconjunctivitis: A Randomized, Double-Blind, Placebo-Controlled Trial
K.-C. Bergmann and T. Zuberbier. Allergy. First published: 10 September 2025
Microenvironment-Driven Mast Cell Plasticity: Insights From Cytokine-Activated Gene Signatures in Skin and Respiratory Diseases
C. Tontini, R. Bahri, A. Higham, et al. Allergy. First published: 10 September 2025
Systematic Review and Meta-Analysis of Oral Immunotherapy Effect on Food Allergy-Related Quality of Life
S. A. Rosser, M. Lloyd, P. Tang, et al. Allergy. First published: 08 September 2025
The Uneven Risks of Childhood Asthma Under Extreme Temperatures and Its Interactions With Environmental Factors
A. Han, S. Deng, S. Wang, et al. Allergy. First published: 05 September 2025
A Streamlined Miniaturized and Multi-Allergen Basophil Activation Test Platform Amenable to Population-Based Study
M. Boussand, M.-E. Castaing-Lasvignottes, K. Leopold, et al. Allergy. First published: 05 September 2025
Recombinant Allergy Vaccine-Induced Transmission of Maternal Allergen-Specific Neutralizing IgG
G. B. Pasikhov, I. P. Shilovskiy, A. A. Nikolskii, et al. Allergy. First published: 05 September 2025
HLA-A*02:01 Presents Penicillin-Modified Cysteinylated Peptides for T Cell Recognition
S. J. R. Goh, H. H. W. Lu, K. E. Scull, et al. Allergy. First published: 04 September 2025
Omics in NSAID-Exacerbated Respiratory Disease: Current Evidence From the Upper and Lower Airways
A. iAkushev, P. Szatkowski, M. Vorobeva, et al. Allergy. First published: 04 September 2025
The Impact of War on Asthma, a Systematic Review and Meta-Analysis: An EAACI Task Force Report
J. Cavaleiro Rufo, I. Paciência, M. Jutel, et al. Allergy. First published: 04 September 2025
Health-Related Quality of Life in Adults With Food Protein-Induced Enterocolitis Syndrome: Generic Versus Allergy-Specific Tools
S. Watanabe, A. Sato, H. Seki, et al. Allergy. First published: 04 September 2025
Cryopreservation Between Sample Processing and Analysis in Streamlined Basophil Activation Test
M.-E. Castaing-Lasvignottes, P. Bourgoin, A. Carsin, et al. Allergy. First published: 03 September 2025
The Expanding Role of ILC2s in Allergic Airways Disease
J. Cain, B. Hurrell, and O. Akbari. Allergy. First published: 02 September 2025
Molecular IgE Sensitization Profiling With Micro-Arrayed Allergen Molecules in Adult Patients With Asthma From the LEAD Cohort: A Precision Medicine Approach
H.-J. Huang, R. Breyer-Kohansal, K. Niespodziana, et al. Allergy. First published: 30 August 2025
Two-Year Turning Point With Dupilumab in CRSwNP: Control, Remission, and Tapering Dosage
E. De Corso, C. Montuori, C. Pipolo, et al. Allergy. First published: 30 August 2025
Molecular Signatures and Functional Pathways of Human Monocytes and Macrophages in Allergy: An EAACI AllergoOncology Scoping Review
R. Bianchini, A. Escolar-Pena, V. Pick, et al. Allergy. First published: 29 August 2025
Myeloid cAMP Reduction Shifts Rhinovirus-Induced Airway Inflammation From Neutrophilic to Eosinophilic by Suppressing M1-Interstitial Macrophages
S. O. Park, E. Uyangaa, H. J. Kim, et al. Allergy. First published: 29 August 2025
Physiological Level of Eosinophils Is Essential for the Regeneration and Homeostasis of Murine Hematopoietic Stem Cells
C. Zhang, W. Yi, Z. Shao, et al. Allergy. First published: 29 August 2025
Development and Characterisation of a New In Vitro Murine Mucosal Mast Cell Model
L. Battut, J. Kamphuis, N. Serhan, et al. Allergy. First published: 29 August 2025
Elevated Cutaneous Interleukin-21 Links Eczematous Eruption to Interleukin-17A Inhibitor Treatment in Psoriasis
L. Zhang, L. Chen, H. Wang, et al. Allergy. First published: 29 August 2025
Microbial Sharing Between Siblings Supports Metabolic Functions Protective Against Allergy
H. Devotta, A. Lavelle, K. Korpela, et al. Allergy. First published: 29 August 2025
From Disease Control to Disease Modification: The Atopic Dermatitis Disease Activity Index
T. Bieber, L. Maintz, G. E. Phad, and M.-C. Brüggen. Allergy. First published: 29 August 2025
Unsupervised Clustering Reveals Intestine-Adapted Eosinophil Subsets Shaped by Local Inflammation
L. D. Larsen, A. Kian, N. A. Falta, et al. Allergy. First published: 28 August 2025
Skin Lipid–Microbe Interplay Links Staphylococcus hominis to Barrier Control in Adult Atopic Dermatitis
M. Bhattacharyya, F. Lauffer, M. Jargosch, et al. Allergy. First published: 28 August 2025
T Cell Subsets Are Altered Off Season in Patients With Allergic Rhinitis
M. Jafari, E. Hjalmarsson, E. Paziou, et al. Allergy. First published:23 August 2025
Novel Humanized Mouse Model for Steroid-Resistant Asthma
S. Yamada, S. Maruoka, S. Toyoshima, et al. Allergy. First published: 23 August 2025
Statistical Analysis in Allergy and Immunology: A Review With Practical Examples
M. Ordak, G. Paoletti, D. Di Bona, et al.Allergy. First published: 23 August 2025
Five-Year Follow-Up Study of Single Dose Challenges in the Diagnosis and Management of Cow's Milk Allergy in Infants
A. Corcoran, Y. d'Art, A. Byrne, and J. O. Hourihane. Allergy. First published: 23 August 2025
Natural History of Airway Hyperresponsiveness and Its Association With Asthma Traits
S. Carra, H. Zhang, R. J. Kurukulaaratchy, and S. H. Arshad. Allergy. First published: 22 August 2025
Narrowband Ultraviolet B Induces Peripheral Regulatory T Cells to Exert Antigen-Specific Immune Suppression
C.-H. Lu, C.-H. Tsai, I. O. Phillip, et al. Allergy. First published: 22 August 2025
Monosodium Glutamate Induces Cellular Stress, Endoplasmic Reticulum Stress, Mitochondrial Dysfunction, and Cell Death in Intestinal Epithelial Cells
B. Zhao, H. Babayev, C. Zeyneloglu, et al.Allergy. First published: 21 August 2025
Anti-IL-5 Vaccination Dampens Allergen-Specific IgE Levels and Modulates IL-4 and IL-5 Th2 Cytokines in Skin Allergy of Mice and Horses
F. Jebbawi, F. Olomski, V. Inversini, et al. Allergy. First published: 21 August 2025
Real-Life Indirect Case Matched Comparison of Dupilumab and Tezepelumab on Airway Oscillometry
R. Greig, R. Chan, and B. Lipworth. Allergy. First published: 19 August 2025
Complementary Predictors for Asthma Attack Prediction in Children: Salivary Microbiome, Serum Inflammatory Mediators, and Past Attack History
S. Shahbazi Khamas, P. Brinkman, A. H. Neerincx, et al.Allergy. First published: 18 August 2025
Itch Sensitivity Questionnaire: A Validated Tool for Assessing Sensitization in Chronic Pruritus
X. Han, X. Wu, Y. Chen, et al. Allergy. First published:18 August 2025
Multi-Ancestry Epigenome-Wide Association Study of Asthma Exacerbations
E. Martin-Gonzalez, J. Perez-Garcia, M. Martin-Almeida, et al. Allergy. First published:18 August 2025
Preventive Role of COVID-19 Vaccination on Future Severe Exacerbation of Asthma According to Severe COVID-19 Status: A Nationwide Population-Based Cohort Study
S. H. Kim, J. G. Jang, M. G. Kang, et al. Allergy. First published: 14 August 2025
Occupational Mite Allergy and Asthma: An EAACI Task Force Report
H. Suojalehto, M. F. Jeebhay, I. Sander, et al.Allergy. First published: 13 August 2025
The Basophil Activation Test Is the Most Accurate Test in Predicting Allergic Reactions to Baked and Fresh Cow's Milk During Oral Food Challenges
I. Bartha, H. Boyd, R.-X. Foong, et al. Allergy. First published: 13 August 2025
Childhood Allergy and Neurodivergence: A Cross-Sectional Analysis in a UK-Birth Cohort
I. Husain, S. Mukhopadhyay, and J. Eccles. Allergy. First published:13 August 2025
Reduced Type-I Interferon by Plasmacytoid Dendritic Cells and Asthma in School-Aged Children
I. Coenen, A. C. Jones, A. A. White, et al. Allergy. First published:13 August 2025
IgG4-Related Disease: Emerging Roles of Novel Genetic Variants, Immune Cell Subsets and Therapeutic Targets
L. Tedesco, S. B. Ali, B. Erman, et al. Allergy. First published: 11 August 2025
Cell Type-Specific IL-5Rα Distribution and IL-5-Induced CCL11 Expression in Human Nasal Epithelium
Y. Kim, M. Kang, J. Seo, et al.Allergy. First published: 11 August 2025
Decrease in Eosinophil-Derived-Neurotoxin With Mepolizumab Is Associated With Asthma Improvement
V. Granger, R. Nadif, L. Orsi, S. et al. Allergy. First published:11 August 2025
An Inflammation-Associated Control Mechanism of Allergy by Proteolysis of IgE
E. Ugarte-Berzal, E. Martens, R. V. S. Pereira, et al.Allergy. First published: 10 August 2025
Epithelial Memory After Respiratory Viral Infection in Mice Results in Prolonged Enhancement of Antigen Presentation
P. P. Janas, W. T'Jonck, M. O. Burgess, et al. Allergy. First published: 07 August 2025
Altered Phage-Related Gene Profiles in Asthmatic Airways
M.-G. Baek, S. Park, Y.-C. Kim, et al. Allergy. First published: 07 August 2025
“Clinical and Biological Remission With Tezepelumab: The Real-World Response in Severe Uncontrolled Asthma”
C. Mümmler and K. Milger. Allergy. First published: 04 August 2025
Correspondence: Dupilumab-Induced Blood Eosinophilia—Why We Need to Look Beyond the Blood
M. Gelardi, R. Giancaspro, and M. Cassano. Allergy. First published: 04 August 2025
Associations Between Blood Eosinophil Surface Proteins and Clinical Traits in Severe Asthma and Chronic Rhinosinusitis With Nasal Polyposis
E. Delaunay, S. Esnault, A. Dendooven, et al. Allergy. First published: 02 August 2025
Bifidobacterium breve M-16V Alleviates Cow's Milk Allergy in a Mouse Model via Gut Microbiota-Derived Indole-3-Propionic Acid-Aryl Hydrocarbon Receptor Signaling Axis
Shao, H., Min, F., Bai, T., et al. Allergy. First published: 01 August 2025
Fungal-Driven Airways Dis-Immunity From Asthma to Allergic Bronchopulmonary Aspergillosis: Dissecting Similarities and Differences
M. Caminati, I. Annesi-Maesano, W. Feleszko, et al. Allergy. First published: 01 August 2025
Neonatal BCG Vaccination Decreases Eczema Incidence at 5 years: The MIS BAIR Randomised Controlled Trial
L. F. Pittet, N. L. Messina, K. L. Francis, et al. Allergy. First published: 31 July 2025
Reply to Correspondence “Omalizumab Reduces Anaphylactic Reactions and Allows Food Introduction in Food-Allergic in Children With Severe Asthma: An Observational Study”
S. Arasi, A. Cafarotti, F. Galletta, et al. Allergy. First published: 30 July 2025
Citations: 342
The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria
Zuberbier, T, Abdul Latiff, AH, Abuzakouk, M, Aquilina, S, Asero, R, Baker, D, et al. Allergy. 2022; 77: 734– 766
Citations: 147
EAACI guidelines: Anaphylaxis (2021 update)
Muraro A, Worm M, Alviani C, et al. Allergy. 2022; 77: 357–377
Citations: 118
The international WAO/EAACI guideline for the management of hereditary angioedema—The 2021 revision and update
Maurer M, Magerl M, Betschel S, et al. Allergy. 2022; 77: 1961–1990
Citations: 118
The role of peripheral blood eosinophil counts in COVID-19 patients
Xie, G, Ding, F, Han, L, Yin, D, Lu, H, Zhang, M. Allergy. 2021; 76: 471– 482
Citations: 114
Epithelial barrier hypothesis: Effect of the external exposome on the microbiome and epithelial barriers in allergic disease
Celebi Sozener Z, Ozdel Ozturk B, Cerci P, et al. Allergy. 2022; 77: 1418–1449
Citations: 105
Basophil activation test: Mechanisms and considerations for use in clinical trials and clinical practice
Santos, A.F., Alpan, O. and Hoffmann, H.-J. Allergy. 2021; 76: 2420-2432
Citations: 92
Allergenic components of the mRNA-1273 vaccine for COVID-19: Possible involvement of polyethylene glycol and IgG-mediated complement activation
Klimek, L., Novak, N., Cabanillas, B., et al. Allergy. 2021; 76: 3307-3313
Citations: 90
EAACI statement on the diagnosis, management and prevention of severe allergic reactions to COVID-19 vaccines
Sokolowska, M., Eiwegger, T., Ollert, M., Torres, M.J., Barber, D., Del Giacco, S., et al. Allergy. 2021; 76: 1629-1639
Citations: 88/h5>
The role of allergen-specific IgE, IgG and IgA in allergic disease
Shamji MH, Valenta R, Jardetzky T, et al. Allergy. 2021; 76: 3627–3641
Citations: 82
COVID-19 pandemic: Practical considerations on the organization of an allergy clinic—An EAACI/ARIA Position Paper
Pfaar, O, Klimek, L, Jutel, M, Akdis, C, A, Bousquet, J, Breiteneder, H, et al. Allergy. 2021; 76: 648– 676
Citations: 81
Advances and highlights in allergic rhinitis
Zhang Y, Lan F, Zhang L. Allergy. 2021; 76: 3383–3389
Citations: 79
Allergic reactions to the first COVID-19 vaccine: A potential role of polyethylene glycol?
Cabanillas, B., Akdis, C.A. and Novak, N. Allergy. 2021; 76: 1617-1618
Citations: 76
Efficacy and safety of treatment with biologicals for severe chronic rhinosinusitis with nasal polyps: A systematic review for the EAACI guidelines
Agache, I., Song, Y., Alonso-Coello, P., Vogel, Y., Rocha, C., Solà, I., et al. Allergy. 2021; 76: 2337-2353
Citations: 74
Interleukin-31: The “itchy” cytokine in inflammation and therapy
Datsi, A., Steinhoff, M., Ahmad, F., Alam, M. and Buddenkotte, J. Allergy. 2021; 76: 2982-2997
Citations: 73
Endotypes of chronic rhinosinusitis: Relationships to disease phenotypes, pathogenesis, clinical findings, and treatment approaches
Kato A, Peters AT, Stevens WW, Schleimer RP, Tan BK, Kern RC. Allergy. 2022; 77: 812–826
Citations: 70
Vaccines and allergic reactions: The past, the current COVID-19 pandemic, and future perspectives
Sampath, V., Rabinowitz, G., Shah, M., et al. Allergy. 2021; 76: 1640-1660
Citations: 69
Advances and highlights in biomarkers of allergic diseases
Ogulur I, Pat Y, Ardicli O, et al. Allergy. 2021; 76: 3659–3686
Citations: 69
Regulatory B cells, A to Z
Jansen, K., Cevhertas, L., Ma, S., Satitsuksanoa, P., Akdis, M. and van de Veen, W.
Citations: 62
Advances and highlights in asthma in 2021
Agache I, Eguiluz-Gracia I, Cojanu C, et al. Allergy. 2021; 76: 3390–3407
Citations: 62
Predictors of treatment response in chronic spontaneous urticaria
Fok, J.S., Kolkhir, P., Church, M.K. and Maurer, M. Allergy. 2021; 76: 2965-2981
Citations: 61
The ingenious mast cell: Contemporary insights into mast cell behavior and function
Dahlin, J.S., Maurer, M., Metcalfe, D.D., Pejler, G., Sagi-Eisenberg, R. and Nilsson, G. Allergy. 2022; 2022; 77: 83-99
The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria
Zuberbier, T, Abdul Latiff, AH, Abuzakouk, M, et al. Allergy. 2022; 77: 734– 766
The EAACI/GA2LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria
Zuberbier, T., Aberer, W., Asero, R., Abdul Latiff, A., H., Baker, D., Ballmer-Weber, B. et al. Allergy. 2018; 73: 1393- 1414
Risk factors for severe and critically ill COVID-19 patients: A review
Gao, Y-D, Ding, M, Dong, X, et al. Allergy. 2021; 76: 428– 455
Vaccines and allergic reactions: the past, the current COVID-19 pandemic, and future perspectives
Sampath, V., Rabinowitz, G., Shah, M., Jain, S., Diamant, Z., Jesenak, M. et al. Allergy. 2021; 76: 1640-1660
Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19
Azkur, A.,K., Akdis, M., Azkur, D., Sokolowska, M., van de Veen, W., Brüggen, M.,C. et al. Allergy. 2020; 75: 1564– 1581
EAACI guidelines: Anaphylaxis (2021 update)
Muraro, A, Worm, M, Alviani, C, et al. Allergy. 2022; 77: 357– 377
Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen)
Bousquet, J., Khaltaev, N., Cruz, A.A., Denburg, J., Fokkens, W.J., Togias, A. et al. Allergy. 2008; 63: 8-160
Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China
Zhang, J.-J., Dong, X., Cao, Y.-Y., Yuan, Y.-D., Yan, Y.-Q., Akdis, C., A. and Gao, Y.-D. Allergy. 2020; 75: 1730– 1741
Advances and recent developments in asthma in 2020
Cevhertas, L, Ogulur, I, Maurer, DJ, et al. Allergy. 2020; 75: 3124– 3146
The international WAO/EAACI guideline for the management of hereditary angioedema – the 2021 revision and update
Maurer, M., Magerl, M., Betschel, S., et al. Allergy. First published: 10 January 2022
A compendium answering 150 questions on COVID-19 and SARS-CoV-2
Riggioni, C., Comberiati, P., Giovannini, M., Agache, I., Akdis, M., Alves-Correia, M. et al. Allergy. 2020; 75: 2503– 2541
Special Issue: Perspectives in Allergen Immunotherapy: 2019 and Beyond
Volume 74 | Issue S108
Management of anaphylaxis due to COVID-19 vaccines in the elderly
Bousquet, J., Agache, I., Blain, H., et al. Allergy. 2021; 76: 2952-2964
Predictors of treatment response in chronic spontaneous urticaria
Fok, J.S., Kolkhir, P., Church, M.K. and Maurer, M. Allergy. 2021; 76: 2965-2981
Interleukin-31: The “itchy” cytokine in inflammation and therapy
Datsi, A., Steinhoff, M., Ahmad, F., Alam, M. and Buddenkotte, J. Allergy. 2021; 76: 2982-2997
Markers for the involvement of endothelial cells and the coagulation system in chronic urticaria: A systematic review
Mostmans, Y., De Smedt, K., Richert, B., et al. Allergy. 2021; 76: 2998-3016
Eczema herpeticum in atopic dermatitis
Traidl, S., Roesner, L., Zeitvogel, J. and Werfel, T. Allergy. 2021; 76: 3017-3027
CytoBas: Precision component-resolved diagnostics for allergy using flow cytometric staining of basophils with recombinant allergen tetramers
McKenzie, C.I., Varese, N., Aui, P.M., et al. Allergy. 2021; 76: 3028-3040
Heterogeneity of pollen food allergy syndrome in seven Southern European countries: The @IT.2020 multicenter study
Lipp, T, Acar Şahin, A, Aggelidis, X, et al. Allergy. 2021; 76: 3041– 3052
Direct assessment of individual skin barrier components by electrical impedance spectroscopy
Mannweiler, R., Bergmann, S., Vidal-y-Sy, S., Brandner, J.M. and Günzel, D. Allergy. 2021; 76: 3094-3106
Prenatal paraben exposure and atopic dermatitis-related outcomes among children
Thürmann, L, Herberth, G, Seiwert, B, et al. Allergy. 2021; 76: 3122– 3132
Free human DNA attenuates the activity of antimicrobial peptides in atopic dermatitis
Kopfnagel, V, Dreyer, S, Zeitvogel, J, et al. Allergy. 2021; 76: 3145– 3154
Nanoarchitectures for efficient IgE cross-linking on effector cells to study amoxicillin allergy
Tesfaye, A., Rodríguez-Nogales, A., Benedé, S., et al. Allergy. 2021; 76: 3183-3193
Sweet syndrome induced by SARS-CoV-2 Pfizer-BioNTech mRNA vaccine
Darrigade, A.-S., Théophile, H., Sanchez-Pena, P., et al. Allergy. 2021; 76: 3194-3196
Transgenic mice overexpressing the PGE2 receptor EP2 on mast cells exhibit a protective phenotype in a model of allergic asthma
Urbano, A., Plaza, J., Turon, S., et al. Allergy. 2021; 76: 3196-3199
Type 2 biomarker expression (FeNO and blood eosinophils) is higher in severe adult-onset than in severe early-onset asthma
Lommatzsch, M., Klein, M., Stoll, P. and Virchow, J.C. Allergy. 2021; 76: 3199-3202
Identification of Ulocladium chartarum as an important indoor allergen source
Pfeiffer, S., Sandler, P., Raith, M., et al. Allergy. 2021; 76: 3202-3206
Effects of allergen immunotherapy in the MASK-air study: a proof-of-concept analysis
Pfaar, O., Sousa-Pinto, B., Devillier, P., et al. Allergy. 2021; 76: 3212-3214
Predicted number of peanut-allergic patients needed to treat with epicutaneous immunotherapy (EPIT) to prevent one allergic reaction: A novel approach to assessing relevance
Remington, B.C., Koppelman, S.J., Green, T.D., et al. Allergy. 2021; 76: 3223-3226
Legends of allergy and immunology: Sergio Bonini
Maltese, G. and Rasi, G. Allergy. 2021; 76: 3227-3229
Medical algorithm: Peri-operative management of mastocytosis patients
Bocca-Tjeertes, I.F.A., van de Ven, A.A.J.M., Koppelman, G.H., et al. Allergy. 2021; 76: 3233-3235
Open Access Agreements with Wiley
Check here if your research institution has an agreement with Wiley to make your Original Articles and Review Articles free to read, download and share by everyone: Institutional Payments | Wiley
Junior Members Corner
What an amazing meeting!
The EAACI Congress in Glasgow this June was a great success, with strong participation from Junior Members in every activity! The JMA organized 7 junior-focused sessions, from cutting-edge science to educational events, alongside our traditional Poster Sessions.
Beyond the sessions, the JMA provided support and guidance through educational initiatives such as the mentorship program, Allergy College, Tell Us About Your Project, the Allergy Quiz... We also held our business meeting, joined task forces, and strengthened collaborations with the EAACI journals.
It is also worth highlighting the collaboration of our juniors in different organizational tasks, their scientific participation as moderators of sessions, and their important educational role in the activities organized by our NAIS and the Allergy Village.
Of course, no EAACI Congress would be complete without our traditional social events, where juniors from all over the world connected, exchanged experiences, and fostered new collaborations.
It was an intense but inspiring few days — we are extremely proud of our juniors and grateful for their passion and dedication. See you at the next EAACI meeting!
Best regards,
The Junior Member Assembly
EAACI Patients Organisation Committee Corner
The POC Reunion in the Annual Congress 2023
The POC has been participating in the EAACI Annual Congresses and focused meetings such as FAAM and PAAM since 2011. When Covid-19 pandemic and strict public health measures started in 2020, POC members continued attending the EAACI events virtually. For the first time in a long while, the POC returned to in-person participation in the Annual Congress Hamburg 2023.
Fifteen members of the committee attended the Annual Congress 2023 in-person. The special session ESS1 which was completely organised by the POC took place on the first day of the Congress with great success. Session was designed to discuss the “Benefits of engaging with patients in clinical trials and decision-making” with different stakeholders.
Giulia Gabrielli from European Medicine Agency (EMA) shared the framework for engagement between the Agency and the patients. Dr Kirsten Perrett, Director of Australia National Allergy Centre of Excellence, shared their experience in receiving the federal funding for allergy prevention and management in collaboration with the POC member Allergy & Anaphylaxis Australia. Susanna Palkonen, Director of European Federation of Allergy and Airways Diseases Patients Associations (EFA) presented their long-lasting track record in participation to research projects. POC Member Mikaela Odemyr, President of Asthma and Allergy Association Sweden shared her experience as a patient representative in participating the research design and planning process.
The session chairs were Carla Jones, CEO of Allergy UK, past POC Co-Chair and Ozlem Ceylan, President of Living with Allergy Association, current POC Chair. The session also had a panel discussion where chairs invited the audience to share their experiences and best practises.
Additionally, POC members Sabine Schnadt (DAAB-Germany) presented “Managing the risk of patients with peanut allergy: the value of thresholds of reaction” in the industry session, Patricia Carmelo and Carolina Olivares (Fundacion Creciendo con Alergias Alimenarias-Chile) had two poster presentations; “Food Allergens that trigger anaphylaxis in children in Chile” and “Adrenaline Auto-injector in Chile, National Survey 2020”.
Several POC members attended the Beat Allergy Run & Walk on the 10th of June. The event was organised to contribute on providing much-needed aid as the collected funds were sent to those affected by the earthquakes in Turkey.
The POC believes the conferences and in-person meetings are useful in staying up to date with new developments in medicine, dissemination of knowledge, enabling interaction with opinion leaders, networking, developing consensus, and adoption of newer ideas relevant to the patient community. Going forward, committee members consider hybrid conventions a decent opportunity to increase accessibility and inclusivity. In 2024, POC is planning to attend the Annual Congress in Valencia and FAAM in Athens.
